Related Experiment Video
Updated: Aug 24, 2026
Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
Published on: January 31, 2022
In silico models for the prediction of dose-dependent human hepatotoxicity
1ADMET R&D, Accelrys, CN5375, Princeton, NJ 08543-5375, USA. cheng189@adelphia.net
Abstract:
The liver is extremely vulnerable to the effects of xenobiotics due to its critical role in metabolism. Drug-induced hepatotoxicity may involve any number of different liver injuries, some of which lead to organ failure and, ultimately, patient death. Understandably, liver toxicity is one of the most important dose-limiting considerations in the drug development cycle, yet there remains a serious shortage of methods to predict hepatotoxicity from chemical structure. We discuss our latest findings in this area and present a new, fully general in silico model which is able to predict the occurrence of dose-dependent human hepatotoxicity with greater than 80% accuracy. Utilizing an ensemble recursive partitioning approach, the model classifies compounds as toxic or non-toxic and provides a confidence level to indicate which predictions are most likely to be correct. Only 2D structural information is required and predictions can be made quite rapidly, so this approach is entirely appropriate for data mining applications and for profiling large synthetic and/or virtual libraries.
Insights
A new in silico model predicts drug-induced hepatotoxicity with over 80% accuracy using only chemical structure. This computational approach aids in identifying liver toxic compounds during drug development.
Area of Science:
- Pharmacology and Toxicology
- Computational Chemistry
- Drug Discovery
Background:
- The liver's central role in metabolism makes it highly susceptible to xenobiotic damage.
- Drug-induced hepatotoxicity is a significant concern in drug development, often limiting dosage and leading to severe outcomes.
- Current methods for predicting hepatotoxicity from chemical structures are insufficient.
Purpose of the Study:
- To develop and present a novel, general in silico model for predicting dose-dependent human hepatotoxicity.
- To improve the accuracy and efficiency of identifying potentially liver-toxic compounds early in the drug development pipeline.
Main Methods:
- Utilized an ensemble recursive partitioning approach for classification.
- Developed a predictive model based on 2D structural information of chemical compounds.
- The model classifies compounds as toxic or non-toxic and provides a confidence score.
Main Results:
- Achieved greater than 80% accuracy in predicting human hepatotoxicity.
- The model requires only 2D structural data, enabling rapid predictions.
- Demonstrated suitability for data mining and profiling large chemical libraries.
Conclusions:
- The developed in silico model offers a highly accurate and rapid method for predicting drug-induced hepatotoxicity.
- This computational tool can significantly aid in the early identification of liver toxicity risks in drug discovery.
- The model's efficiency makes it valuable for screening extensive synthetic and virtual compound libraries.
Related Concept Videos
01:07Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion, mediated...
01:23Toxicity Testing in Animals
01:29Pharmacodynamic Models: Direct Effect Model and Indirect Response Model
01:26Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions